hydroxychloroquine has been researched along with vorinostat in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Amaravadi, RK; Carew, JS; Curiel, TJ; Davis, LE; Espitia, CM; Giles, FJ; Mahalingam, D; Mita, AC; Mita, M; Nawrocki, ST; Sarantopoulos, J; Wood, L | 1 |
| Curiel, T; Goros, M; Hurez, V; Mahalingam, D; Michalek, J; Nawrocki, ST; Patel, S; Sarantopoulos, J | 1 |
| Arora, SP; Curiel, T; Liu, Q; Mahalingam, D; Mendez, JA; Michalek, J; Morris, J; Sarantopoulos, J; Tenner, L | 1 |
1 review(s) available for hydroxychloroquine and vorinostat
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for hydroxychloroquine and vorinostat
| Article | Year |
|---|---|
Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Demography; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Hydroxychloroquine; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Neoplasms; Treatment Outcome; Vorinostat | 2014 |
Modulation of autophagy: a Phase II study of vorinostat plus hydroxychloroquine versus regorafenib in chemotherapy-refractory metastatic colorectal cancer (mCRC).
Topics: Antineoplastic Combined Chemotherapy Protocols; Autophagy; Colorectal Neoplasms; Humans; Hydroxychloroquine; Middle Aged; Phenylurea Compounds; Prospective Studies; Pyridines; Vorinostat | 2022 |
2 other study(ies) available for hydroxychloroquine and vorinostat
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Vorinostat and hydroxychloroquine improve immunity and inhibit autophagy in metastatic colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Colorectal Neoplasms; Fatigue; Female; Humans; Hydroxamic Acids; Hydroxychloroquine; Immunity, Cellular; Male; Middle Aged; Neoplasm Metastasis; Survival Analysis; T-Lymphocytes, Regulatory; Treatment Outcome; Vorinostat | 2016 |